Genmab — April 2024
-
still begs the question - is GEN buying an ADC platform, or a pipeline?
-
pfizer bled usd 40b for Seagen to enter that space
-
AACR '24 - New Technologies
2050 / 7 - Preclinical characterization of PRO1106, a novel and promising SLITRK6-directed sesutecan ADC - https://www.abstractsonline.com/pp8/#!/20272/presentation/6890 -
AACR '24 - New Therapies
6580 - A Novel EGFR x cMET bispecific ADC PRO1286 demonstrated broad antitumor activity and promising tolerability in preclinical models - https://www.abstractsonline.com/pp8/#!/20272/presentation/7457 -
AACR '24 - Late-Breaking Research: Experimental and Molecular Therapeutics 4
LB425 / 1 - A tumor microenvironment-targeting CD98-directed ADC confers robust anti-tumor activity in multiple cancers with favorable pharmacokinetics and safety profiles in preclinical models https://www.abstractsonline.com/pp8/#!/20272/presentation/10475 -
must be profoundbio - if you check the duplicate surnames for the presenters, they all have the same first name letter abbreviation.
-
I'm no expert in chinese names - but that is too much of a coincidence...
-
-
two souls...
-
seems there is no presentation to go with the CC
-
aah - click on "Go to webcast" and the presentation is thre
-
Rina-s ~ "reiner arsch"
-
Holy fuck that is funny!
-
Rina-s på markedet 2027 if all goes well
-
all cash, debt free transaction
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind